Clinical characteristics of the study participants
TYPE 1 DIABETES
From October 2018 to September 2019, a total of 273 eligible participants were randomly assigned to the unblinded isCGM (n = 199) group or the blinded isCGM group (n = 78). The 12-week visit was completed by 152 participants (75%) in the unblinded isCGM and 64 participants (82%) in the blinded isCGM group (flow of participants in a study of the efficacy of unblinded and blinded intermittently flash continuous glucose monitoring on glycemic control in adults with type 1 diabetes.The included participants had comparable baseline characteristics (Baseline characteristics of participants in a study of the efficacy of unblinded and blinded intermittently flash continuous glucose monitoring on glycemic control in adults with type 1 diabetes.